Author

A. Pierson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

M. Boulpicante· 2 shared R. Darrigrand· 2 shared S. Apcher· 2 shared A. Bachi· 1 shared A. Cattaneo· 1 shared B. Gaudineau· 1 shared C. Garcia· 1 shared C. Lobry· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Boulpicante

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Splicing inhibition enhances the antitumor immune response through increased tumor antigen presentation and altered MHC-I immunopeptidome

A. Pierson, R. Darrigrand, M. Rouillon, M. Boulpicante, Z. D. Renko, C. Garcia, M. Ghosh, M.-C. Laiguillon, C. Lobry, M. Alami, S. Apcher

This study shows that splicing inhibition with IP2 enhances antitumor immunity by increasing antigen presentation and altering MHC-I immunopeptidomes.

bioRxiv · Jan 6, 2019 · PreprintImmunology

Tumors escape immunosurveillance by overexpressing the proteasome activator REGγ

M. Boulpicante, R. Darrigrand, A. Pierson, V. Salgues, B. Gaudineau, M. Khaled, A. Cattaneo, A. Bachi, P. Cascio, S. Apcher

The paper shows cancer cells evade immunosurveillance by upregulating REGγ, which increases destruction of MHC-I peptides generated from nuclear translation products.

bioRxiv · Jan 6, 2019Immunology